mcrc维持治疗的方案探讨与思考.pptVIP

mCRC维持治疗的方案探讨与思考;mCRC维持诊疗背景与理论基础; 维持诊疗优势: 降低化疗药品累积毒性 降低诊疗费用 保留患者继续接收深入诊疗能力 提升生活质量;Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. ;Lancet. 2003 Feb 8;361(9356):457-64.;Intermittent 10.8 mth;结论;1. Tournigand, et al. JCO 2006 2. Maindrault-Goebel, et al. ASCO 2007;OPTIMOX2研究结果;多少患者能拥有3个月无化疗间期（CFI）？;在3个月无化疗间期前最好化疗连续时间是多久？;维持诊疗: 优化mCRC姑息诊疗关键策略;卡培她滨一线维持诊疗;Waddell T, Gollins S, Soe W, et al. Phase Ⅱ study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance c